← 產業報告目錄
Sprycel Market Size, Share & Trends Analysis Report By Demographic (Age, Gender, Income), By Psychographic (Lifestyle, Attitudesa), By Behavioral, (Usage Rate, Compliance, Treatment), By Medical (Indication, Disease Stage), By Region, And By Segment Forecasts, 2023-2031.
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-29頁數 180報告編號 INSIGHTACE-ef7ca66033
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Sprycel Market stood at USD 5.47 Bn in 2022, and is poised to reach USD 8.52 Bn by 2031, recording a CAGR of 5.2% from 2023 through 2031.
The Sprycel sector involves treated with it. This domain has witnessed considerable transformation owing to technological breakthroughs and shifting healthcare dynamics.
Several factors contribute to this trajectory, including heightened appetite for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region poised to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Sprycel Market Snapshot
Chapter 4. Global Sprycel Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Demographic Estimates & Trend Analysis
5.1. By Demographic, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Demographic:
5.2.1. Age
5.2.2. Gender
5.2.3. Income
Chapter 6. Market Segmentation 2: By Psychographic Estimates & Trend Analysis
6.1. By Psychographic & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Psychographic:
6.2.1. Lifestyle
6.2.2. Attitudes
Chapter 7. Market Segmentation 3: By Behavioral Estimates & Trend Analysis
7.1. By Behavioral & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Behavioral:
7.2.1. Usage Rate
7.2.2. Compliance
7.2.3. Treatment History
Chapter 8. Market Segmentation 4: By Medical Estimates & Trend Analysis
8.1. By Medical & Market Share, 2020 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Medical:
8.2.1. Indication
8.2.2. Disease Stage
Chapter 9. Sprycel Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Sprycel Market revenue (US$ Million) estimates and forecasts By Demographic, 2019-2031
9.1.2. North America Sprycel Market revenue (US$ Million) estimates and forecasts By Psychographic, 2019-2031
9.1.3. North America Sprycel Market revenue (US$ Million) estimates and forecasts By Behavioral, 2019-2031
9.1.4. North America Sprycel Market revenue (US$ Million) estimates and forecasts By Medical, 2019-2031
9.1.5. North America Sprycel Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
9.2. Europe
9.2.1. Europe Sprycel Market revenue (US$ Million) By Demographic, 2019-2031
9.2.2. Europe Sprycel Market revenue (US$ Million) By Psychographic, 2019-2031
9.2.3. Europe Sprycel Market revenue (US$ Million) By Behavioral, 2019-2031
9.2.4. Europe Sprycel Market revenue (US$ Million) By Medical, 2019-2031
9.2.5. Europe Sprycel Market revenue (US$ Million) by country, 2019-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Sprycel Market revenue (US$ Million) By Demographic, 2019-2031
9.3.2. Asia Pacific Sprycel Market revenue (US$ Million) By Psychographic, 2019-2031
9.3.3. Asia Pacific Sprycel Market revenue (US$ Million) By Behavioral, 2019-2031
9.3.4. Asia Pacific Sprycel Market revenue (US$ Million) By Medical, 2019-2031
9.3.5. Asia Pacific Sprycel Market revenue (US$ Million) by country, 2019-2031
9.4. Latin America
9.4.1. Latin America Sprycel Market revenue (US$ Million) By Demographic, (US$ Million) 2019-2031
9.4.2. Latin America Sprycel Market revenue (US$ Million) By Psychographic, (US$ Million) 2019-2031
9.4.3. Latin America Sprycel Market revenue (US$ Million) By Behavioral, (US$ Million) 2019-2031
9.4.4. Latin America Sprycel Market revenue (US$ Million) By Medical, (US$ Million) 2019-2031
9.4.5. Latin America Sprycel Market revenue (US$ Million) by country, 2019-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Sprycel Market revenue (US$ Million) By Demographic, (US$ Million) 2019-2031
9.5.2. Middle East & Africa Sprycel Market revenue (US$ Million) By Psychographic, (US$ Million) 2019-2031
9.5.3. Middle East & Africa Sprycel Market revenue (US$ Million) By Behavioral, (US$ Million) 2019-2031
9.5.4. Middle East & Africa Sprycel Market revenue (US$ Million) By Medical, (US$ Million) 2019-2031
9.5.5. Middle East & Africa Sprycel Market revenue (US$ Million) by country, 2019-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profile
10.2.1. Bristol-Myers Squibb (BMS)
10.2.2. Novartis
10.2.3. Teva Pharmaceutical Industries
10.2.4. Mylan
10.2.5. Accord Healthcare
10.2.6. Sun Pharma
10.2.7. Dr. Reddy's Laboratories
10.2.8. Aurobindo Pharma
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們